Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 10, Issue 3, Pages 403-404Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2007.1926
Keywords
-
Funding
- NHLBI NIH HHS [HL 22559, HL 34360] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034360, R01HL022559] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Resveratrol, a red wine and grape-derived phytoalexin, possesses diverse biochemical and physiological functions that are relevant to human health and disease. The emergent properties of resveratrol have forced us to rethink the biomedical significance of the wine culture. Novel observations point to the hypothesis that intracerebral resveratrol treatment diminishes the sensitivity of rats to pain, and that the said analgesic action of resveratrol is a central mechanism mediated by the inhibition of cycloxygenases I and II. This novel implication of resveratrol and perhaps red wine drinking warrants further studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available